Tramiprosate

N/A

Report date: 2024/05/29 20:00:36
NME

Base Information

Drug NameTramiprosate
Drug Alias NameHomotaurineAlzhemedCerebrilVivimindNC-531 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsGlaucomaNeurodegenerative DiseasesAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[12] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBellus Health Inc
China Registration ClassN/A

Develop Information

Active CompaniesSapienza University Of RomeFederico Ii University
Inactive CompaniesBellus Health Inc
Active IndicationsGlaucoma
Inactive IndicationsNeurodegenerative DiseasesAlzheimer DiseaseStroke

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG